Evidence map›Paper›PMID 25777973›Full record

ArticleInternational journal of molecular medicine2015

Ser341Pro MYOC gene mutation in a family with primary open-angle glaucoma.

Fengyun Wang, Yang Li, Lan Lan, Bo Li, Li Lin, Xiaohe Lu, Jiping Li

Open access · hybridAbstract read
In one paragraph

Article in International journal of molecular medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Clinical and genetic analysis of Ser341ProInternational journal of ophthalmology · 2020
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Fengyun WangDepartment of Ophthalmology, The First Affiliated Hospital, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Yang LiBeijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Science Key Laboratory, Beijing 100730, P.R. China.
Lan LanDepartment of Ophthalmology, The First Affiliated Hospital, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Bo LiDepartment of Ophthalmology, The First Affiliated Hospital, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Li LinDepartment of Ophthalmology, The First Affiliated Hospital, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Xiaohe LuDepartment of Ophthalmology, Zhujing Hospital, Nanfang Medical University, Guangzhou, Guangdong 510515, P.R. China.
Jiping LiDepartment of Ophthalmology, The First Affiliated Hospital, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
First Affiliated Hospital of Henan University of Science and Technology · CNBeijing Tongren Hospital · CNNanfang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glaucoma is known to induce visual impairment and blindness. The aim of the present study was to determine the clinical and genetic findings of a family with primary open-angle glaucoma (POAG). A family diagnosed with glaucoma was examined clinically and followed up for five years. Genomic DNA was extracted from the venous blood of 12 family members, and of 100 healthy individuals. The mode of inheritance was determined by the pedigree analysis. The third exon and its flanking introns of myocilin (MYOC) were amplified, and quantitative polymerase chain reaction (qPCR) products were sequenced. The restriction fragment length polymorphism analysis was performed on samples from the 12 family members and 100 normal controls. The predicted effects of the detected variants on the secondary structure of the MYOC protein were analyzed by the Garnier-Osguthorpe-Robson method. In this family, three members were diagnosed with POAG, and one member with ocular hypertension. The mode of inheritance of the family was autosomal dominant with six members being genetically affected. The heterozygous mutation was identified in the third exon of MYOC that revealed a T → C transition at position 1021 (p.S341P), which switched serine (Ser) to proline (Pro). This is a missense mutation eliminating a CviKI-1 restriction site that segregated the affected members. Secondary structure prediction of p.S341P suggested that the MYOC protein was misfolded. Ser341Pro MYOC mutation was detected in the family with POAG. The clinical and genetic characteristics of this mutation require further investigation. The mutation spectrum of MYOC may be expanded for a better diagnosis and treatment for POAG patients.

Indexed as

Amino Acid SubstitutionMutationAdultAgedAged, 80 and overAmino Acid SequenceCytoskeletal ProteinsEye ProteinsFamilyFemaleFollow-Up StudiesGlaucoma, Open-AngleGlycoproteinsHumansMaleMiddle AgedCytoskeletal ProteinsEye ProteinsGlycoproteinsMyocilin

Identifiers

PMID25777973
PMCPMC4380197
OpenAlexW2026712888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.